Azole–carbodithioate hybrids as vaginal anti-Candida contraceptive agents: Design, synthesis and docking studies
摘要:
Azole and carbodithioate hybrids were synthesized as alkyl 1H-azole-1-carbodithioates (7-27) and evaluated for spermicidal/microbicidal activities against human sperm, Trichomonas vaginalis and Candida species. Seventeen compounds (7-14, 16-18 and 20-25) showed spermicidal activity at MEC 1.0% (w/v) and permanently immobilized 100% normal human spermatozoa within similar to 30 s. Seventeen compounds (7-11, 13-18 and 20-25) exhibited anti-Candida activity (IC50 1.26-47.69 mu g/mL). All compounds were devoid of bactericidal activity against four bacterial strains (50.00 mu g/mL) and antiprotozoal activity against Trichomonas vaginalis (200.00 mu g/mL). Four promising compounds (10, 17, 20 and 22) have better safety profile as compared to Nonoxyno1-9 (N-9). Docking study was done to visualize the possible interaction of designed scaffold with prospective receptor (Cyp51) of Candida albicans. (C) 2013 Elsevier Masson SAS. All rights reserved.
Die vorliegende Erfindung betrifft neue chemische Wirkstoffe gegen Erkrankungen, die durch Helminthen hervorgerufen werden (z. B. Schistosomiasis). Sie umfasst im wesentlichen Verbindungen mit mindestens einer Dithiocarbamat-und/oder Dithiocarbazat-Teilstruktur.
Azole–carbodithioate hybrids as vaginal anti-Candida contraceptive agents: Design, synthesis and docking studies
作者:Lalit Kumar、Nand Lal、Vikash Kumar、Amit Sarswat、Santosh Jangir、Veenu Bala、Lokesh Kumar、Bhavana Kushwaha、Atindra K. Pandey、Mohammad I. Siddiqi、Praveen K. Shukla、Jagdamba P. Maikhuri、Gopal Gupta、Vishnu L. Sharma
DOI:10.1016/j.ejmech.2013.09.007
日期:2013.12
Azole and carbodithioate hybrids were synthesized as alkyl 1H-azole-1-carbodithioates (7-27) and evaluated for spermicidal/microbicidal activities against human sperm, Trichomonas vaginalis and Candida species. Seventeen compounds (7-14, 16-18 and 20-25) showed spermicidal activity at MEC 1.0% (w/v) and permanently immobilized 100% normal human spermatozoa within similar to 30 s. Seventeen compounds (7-11, 13-18 and 20-25) exhibited anti-Candida activity (IC50 1.26-47.69 mu g/mL). All compounds were devoid of bactericidal activity against four bacterial strains (50.00 mu g/mL) and antiprotozoal activity against Trichomonas vaginalis (200.00 mu g/mL). Four promising compounds (10, 17, 20 and 22) have better safety profile as compared to Nonoxyno1-9 (N-9). Docking study was done to visualize the possible interaction of designed scaffold with prospective receptor (Cyp51) of Candida albicans. (C) 2013 Elsevier Masson SAS. All rights reserved.